EMA Updates Drug Development Advice for Inflammatory Diseases

International Pharmaceutical Regulatory Monitor
A A
The European Medicines Agency released new guidelines on developing treatments for Crohn’s disease and ulcerative colitis set to take effect Jan. 1.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor

Buy This Article Now

Add this article to your cart for $40.00